Omega Fund Management as of June 30, 2019
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 15 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gossamer Bio (GOSS) | 39.3 | $154M | 7.0M | 22.18 | |
| Replimune Group (REPL) | 19.0 | $75M | 5.1M | 14.61 | |
| Morphic Hldg (MORF) | 15.0 | $59M | 3.0M | 19.82 | |
| Translate Bio | 7.8 | $31M | 2.4M | 12.63 | |
| Immunic (IMUX) | 4.0 | $16M | 1.4M | 11.47 | |
| Obseva Sa | 2.9 | $11M | 999k | 11.31 | |
| Paratek Pharmaceuticals | 2.6 | $10M | 2.6M | 3.99 | |
| Trevi Therapeutics (TRVI) | 2.4 | $9.5M | 1.3M | 7.50 | |
| Prevail Therapeutics Ord | 2.2 | $8.8M | 669k | 13.20 | |
| Fibrogen (FGEN) | 1.5 | $5.9M | 131k | 45.18 | |
| Pieris Pharmaceuticals (PIRS) | 0.9 | $3.5M | 755k | 4.70 | |
| Essa Pharma (EPIX) | 0.7 | $2.7M | 1.1M | 2.45 | |
| Jounce Therapeutics | 0.7 | $2.6M | 530k | 4.95 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.7 | $2.5M | 1.5M | 1.68 | |
| Sienna Biopharmaceuticals (SNNAQ) | 0.2 | $660k | 759k | 0.87 |
